Mode
Text Size
Log in / Sign up

Tumor

Part of Cancer

12 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for tumor

37 trials tracked for tumor: 4 in phase 3 or 4 and 1 with published results. The most-cited published study has 62 citations.

37Trials tracked
4Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 3 Phase 2 16 Phase 1 13 Other / NA 4
  1. Phase 3 Additive Homeopathy in Cancer Patients Completed · 62 cited
  2. Phase 4 Dexmedetomidine and Propofol for Pediatric MRI Sedation Completed
  3. Phase 3 Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer Completed
  4. Phase 3 A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine Completed
  5. Phase 2 A Study of Atezolizumab in Advanced Solid Tumors Completed
  6. Phase 2 Oral Topotecan to Treat Recurrent or Persistent Solid Tumors Completed
Show 31 more trials
  1. Phase 2 PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) Completed
  2. Phase 2 A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors Completed
  3. Phase 2 Study of BMS-986158 in Subjects With Select Advanced Cancers Completed
  4. Phase 2 Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours Completed
  5. Phase 2 A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer Completed
  6. Phase 2 Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors Completed
  7. Phase 2 A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors Completed
  8. Phase 2 A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors Completed
  9. Phase 2 Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours Completed
  10. Phase 2 Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma Completed
  11. Phase 2 NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b) Completed
  12. Phase 2 Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Completed
  13. Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer Completed
  14. Phase 2 Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer Completed
  15. Phase 1 A Study of IMC-TR1 in Participants With Advanced Solid Tumors Completed
  16. Phase 1 MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies Completed
  17. Phase 1 A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) Completed
  18. Phase 1 NY-ESO-1 Protein With Montanide and CpG 7909 as Cancer Vaccine in Several Tumors Completed
  19. Phase 1 A Study of IMC-A12 in Advanced Solid Tumors Completed
  20. Phase 1 Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults Completed
  21. Phase 1 First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors Completed
  22. Phase 1 A Study of Oral Suberoylanilide Hydroxamic Acid (Vorinostat) in Patients With Solid Tumors (0683-048) Completed
  23. Phase 1 A Study to Evaluate Biomarkers in Patients With Solid Tumors (0000-097)(COMPLETED) Completed
  24. Phase 1 Phase 1 Study of E7090 in Subjects With Solid Tumor Completed
  25. Phase 1 A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors Completed
  26. Phase 1 Study of Dasatinib (BMS-354825) in Patients With Solid Tumors Completed
  27. Phase 1 Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors Completed
  28. N/A The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy Completed
  29. N/A Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging Completed
  30. N/A High-density EEG in Neurological Disorders Completed
  31. N/A MaxAn Post Market Surveillance Validation Completed

Showing the 37 most-cited and recently-updated of 37 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.